Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previously, a number of microRNAs (miRs) have been identified to participate in the development and progression of
glioma
via the regulation of their target genes. However, the molecular mechanisms underlying the effect of miR-423-3p in
glioma
growth remain unclear. In the present study, the reverse transcription-quantitative polymerase chain reaction and western blotting were used to assess the mRNA and protein expression levels of miR-423-3p, respectively. An MTT assay and flow cytometry were performed to determine cell proliferation and apoptosis, respectively. A luciferase reporter gene assay was performed to determine the target association between
pannexin 2
(
PANX2
) and miR-423-3p. It was revealed that miR-423-3p was significantly upregulated in
glioma
tissues compared with normal brain tissues, and the increased expression of miR-423-3p was significantly associated with an advanced grade as well as a poorer prognosis of patients with
glioma
. Inhibition of miR-423-3p using an miR-423-3p inhibitor resulted in the decreased proliferation of
glioma
U251 and U87MG Uppsala cells, and the induction of apoptosis.
PANX2
was identified as a novel target gene of miR-423-3p, and the expression of
PANX2
was revealed to be increased in U251 and U87MG Uppsala cells when miR-423-3p was inhibited. Knockdown of
PANX2
attenuated the effects of miR-423-3p inhibition on
glioma
cell proliferation and apoptosis. Furthermore,
PANX2
was significantly downregulated in
glioma
tissues compared with normal brain tissues, and its levels were markedly lower in World Health Organization (WHO) stage III-IV gliomas compared with WHO stage I-II gliomas. Additionally, the expression levels of
PANX2
were identified to be inversely correlated with miR-423-3p expression levels in
glioma
tissues. Consequently, targeting miR-423-3p may inhibit
glioma
growth via the upregulation of
PANX2
.
...
PMID:MicroRNA-423-3p promotes glioma growth by targeting PANX2. 2992 99